The U.S. FDA granted Abbott Breakthrough Device designation to explore deep brain stimulation (DBS) for treatment-resistant depression (TRD) as an option to improve the lives of people with this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results